| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
TriSalus Life Sciences, Inc.
13D/A
TLSI · 89680M101
|
6.0% |
8/1/2025
Event 7/31/2025
|
||||
| Mats Wahlstrom | 6.0% | |||||
| Kerry R. Hicks | 4.7% | |||||
| HW Investment Partners, LLC | 2.8% | |||||
| HW Investment Partners, LLC | 2.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.